Market News
Stay updated with the latest market trends, earnings, and economic indicators.
GIFT Nifty rises 100 points, hints at positive start; key trading cues for today
Indian markets closed higher on Tuesday, boosted by banking and financial stocks. The Reserve Bank of India's new forex swap facility eased overseas borrowing concerns. Market sentiment improved with hopes of a Middle East truce and falling crude oil prices. Investors remain watchful due to ongoing geopolitical tensions and inflation worries.
Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, Vedanta
Indian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but uncertainty persists due to mixed heavyweight stock trends. Investors are advised to focus on stock-specific opportunities as analysts maintain a cautious outlook.

Dharana Capital buys 12-14% stake worth ₹225 crore in Mygate
The transaction values the residential community management platform between ₹2,100 crore and ₹2,300 crore. The fresh capital will be used to fund India expansion, new payment products and overseas pilots.

Oman India Fund sells Capital Small Finance Bank shares worth ₹37 crore
An Oman-backed private equity fund has sold a 3.65% stake in Capital Small Finance Bank for nearly ₹37 crore through a block deal, with Lyptus Punch-Card Fund picking up the entire stake at a slight discount to the market price.

Jio BlackRock prepares ETF debut by August after building $2 billion India fund base By Reuters - Investing.com
Jio BlackRock prepares ETF debut by August after building $2 billion India fund base By ReutersInvesting.com
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
INR recovers momentum as local equities rebound; recent oil and dollar spike fades amid signs of easing geopolitical tensions
The Indian rupee recovered momentum to settle higher by around 28 paise at Rs 95.31 per dollar on Tuesday, supported by retreating international oil prices and small pullback in dollar overseas. Meanwhile, local equities also rebounded from two-month lows as a halt in hostilities between Israel and Iran boosted hopes that peace negotiations could move forward. Geopolitical tensions eased somewhat, the dollar weakened and Brent crude futures fell below $93 a barrel as Israel and Iran agreed to halt attacks against each other following a series of mutual attacks from Sunday night, which marked the most serious escalation since the ceasefire in April. The BSE Sensex settled 394.50 points (0.54%) higher at 73,918.76, while the NSE Nifty 50 advanced 119.10 points (0.52%) to close at 23,242.10.
From tax exemption to FCNR(B) deposits: How India is trying to attract foreign capital
India is taking steps to attract foreign investment and boost its economy. The Reserve Bank of India and the government have introduced new measures. These aim to bring in more dollars and stabilize the rupee. The initiatives include special swap facilities and tax exemptions for foreign investors. These actions are designed to make Indian markets more appealing to overseas capital.

Should You Own More Gold? Experts Weigh In After ETF Restrictions Across Mutual Funds
Both advisors argued that the discussion should not be limited to gold. Instead, it should prompt investors to think more broadly about diversification.